SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹104,739 Cr | ₹87,693 Cr | ₹81,396 Cr | ₹77,225 Cr | ₹66,958 Cr |
What is the latest Total Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹104,739 Cr |
| Mar2025 | ₹87,693 Cr |
| Mar2024 | ₹81,396 Cr |
| Mar2023 | ₹77,225 Cr |
| Mar2022 | ₹66,958 Cr |
How is Total Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹104,739 Cr | 19.44 | |
| Mar2025 | ₹87,693 Cr | 7.74 | |
| Mar2024 | ₹81,396 Cr | 5.40 | |
| Mar2023 | ₹77,225 Cr | 15.33 | |
| Mar2022 | ₹66,958 Cr | - | |
Compare Total Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,262.8 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| MANKIND PHARMA | ₹101,638.0 Cr | -5.1% | -3.1% | -2.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -1.5% |
2.5% |
14.5% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses